Stockreport

Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... [Yahoo! Finance]

Karyopharm Therapeutics Inc.  (KPTI) 
Last karyopharm therapeutics inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.karyopharm.com/investor-relations
PDF Gross to Net Discount for XPOVIO: 31% in Q3 2024, up from 21% in Q3 2023. R&D Expenses: $36.1 million for Q3 2024, compared to $35.6 million for Q3 2023. SG&A Expen [Read more]